60
Participants
Start Date
March 24, 2021
Primary Completion Date
March 17, 2025
Study Completion Date
March 17, 2025
Ophthalmologic exam at inclusion and 12 months after CRVO
"As part of routine care : OCT-B (Optical coherence tomography-B), OCT-angiography (Optical coherence tomography and fluorescein angiography after pupillary dilatation (at inclusion only)~Added by the study :~* Assessment of best corrected visual acuity in letters read and validated using the ETDRS scale ;~* The shooting of a 10 second infrared movie by the Heidelberg Spectralis device centered on the head of the optic nerve (at inclusion only)~* A measurement of the eye tension with an air tonometer (at inclusion only)~* A blood pressure measurement (diastolic and systolic) and pulse measurement (at inclusion only)~* A color retinophotography (Optos) with autofluorescence images~* A color Doppler ultrasound of the optic nerve of both eyes will be performed, for patients treated at the Foundation A de Rothschild Hospital only."
Treatment standardization with aflibercept
For patients requiring intravitreal injection
Centre médical et chirurgical de la rétine Strasbourg, Strasbourg
Centre Pôle Vision du Val d'ouest, Lyon, Écully
Hôpital Fondation A. de Rothschuld, Paris
Collaborators (1)
Bayer
INDUSTRY
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK